Enhancer architecture sensitizes cell specific responses to <i>Notch</i> gene dose via a bind and discard mechanism.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32297857.
- Also identified by DOI 10.7554/eLife.53659 and PMC identifier 7213981.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Notch pathway haploinsufficiency can cause severe developmental syndromes with highly variable penetrance. Currently, we have a limited mechanistic understanding of phenotype variability due to gene dosage. Here, we unexpectedly found that inserting an enhancer containing pioneer transcription factor sites coupled to Notch dimer sites can induce a subset of <i>Notch</i> haploinsufficiency phenotypes in <i>Drosophila</i> with wild type <i>Notch</i> gene dose. Using <i>Drosophila</i> genetics, we show that this enhancer induces Notch phenotypes in a Cdk8-dependent, transcription-independent manner. We further combined mathematical modeling with quantitative trait and expression analysis to build a model that describes how changes in Notch signal production versus degradation differentially impact cellular outcomes that require long versus short signal duration. Altogether, these findings support a 'bind and discard' mechanism in which enhancers with specific binding sites promote rapid Cdk8-dependent Notch turnover, and thereby reduce Notch-dependent transcription at other loci and sensitize tissues to gene dose based upon signal duration.
Medical subject headings
- Drosophila Proteins
- Enhancer Elements, Genetic
- Haploinsufficiency
- Models, Genetic
- Models, Theoretical
- Receptors, Notch